JESSICA MARINO: Open Payments
NPI 1326346933 · JERSEY CITY, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,170 in 45 payments from 12 companies in 2025. Trend: 2023 $46 · 2024 $757 · 2025 $1,170
Food & beverage: $1,170
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 18 | $566 |
| Merck Sharp & Dohme LLC | 11 | $178 |
| GlaxoSmithKline, LLC. | 2 | $140 |
| Novartis Pharmaceuticals Corporation | 4 | $66 |
| Philips North America LLC | 1 | $54 |
| Lilly USA, LLC | 2 | $36 |
| Amgen Inc. | 2 | $29 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $25 |
| AtriCure, Inc. | 1 | $23 |
| E.R. Squibb & Sons, L.L.C. | 1 | $19 |
Products named: Wegovy, VERQUVO, Ozempic, AREXVY, LEQVIO, MCOT, Saxenda, REPATHA.
Industry payments across NJ — which companies pay providers there.
